FR2553100B1 - Compositions renfermant des proteines de la membrane cellulaire de lymphocytes t, et procede de preparation de cette composition - Google Patents

Compositions renfermant des proteines de la membrane cellulaire de lymphocytes t, et procede de preparation de cette composition

Info

Publication number
FR2553100B1
FR2553100B1 FR848413916A FR8413916A FR2553100B1 FR 2553100 B1 FR2553100 B1 FR 2553100B1 FR 848413916 A FR848413916 A FR 848413916A FR 8413916 A FR8413916 A FR 8413916A FR 2553100 B1 FR2553100 B1 FR 2553100B1
Authority
FR
France
Prior art keywords
cell
compositions containing
preparing
same
containing proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR848413916A
Other languages
English (en)
Other versions
FR2553100A1 (fr
Inventor
Irun Robert Cohen
Meir Shinitzky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of FR2553100A1 publication Critical patent/FR2553100A1/fr
Priority claimed from EP87113856A external-priority patent/EP0261648B1/fr
Application granted granted Critical
Publication of FR2553100B1 publication Critical patent/FR2553100B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
FR848413916A 1983-09-11 1984-09-11 Compositions renfermant des proteines de la membrane cellulaire de lymphocytes t, et procede de preparation de cette composition Expired FR2553100B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL69686A IL69686A (en) 1983-09-11 1983-09-11 Compositions containing cell membrane proteins and process for their preparation
US06/910,876 US4996194A (en) 1983-09-11 1986-09-23 Pressure treated autoimmune specific T cell compositions
EP87113856A EP0261648B1 (fr) 1986-09-23 1987-09-22 Protéines de membrane cellulaire, compositions les contenant et procédé pour les préparer

Publications (2)

Publication Number Publication Date
FR2553100A1 FR2553100A1 (fr) 1985-04-12
FR2553100B1 true FR2553100B1 (fr) 1989-09-01

Family

ID=37781888

Family Applications (1)

Application Number Title Priority Date Filing Date
FR848413916A Expired FR2553100B1 (fr) 1983-09-11 1984-09-11 Compositions renfermant des proteines de la membrane cellulaire de lymphocytes t, et procede de preparation de cette composition

Country Status (9)

Country Link
US (2) US4634590A (fr)
JP (1) JPH0641421B2 (fr)
AT (1) ATE83151T1 (fr)
CA (1) CA1235660A (fr)
DE (1) DE3433339C2 (fr)
FR (1) FR2553100B1 (fr)
GB (1) GB2146338B (fr)
IL (1) IL69686A (fr)
IT (1) IT1210493B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35277E (en) * 1983-09-11 1996-06-18 Yeda Research And Development Co. Ltd. Cell membrane proteins, compositions containing them and procedure for their preparation
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
US4931275A (en) * 1985-12-02 1990-06-05 Yeda Research & Development Co., Ltd. Anti-tumor vaccines and their preparation
GB8610983D0 (en) * 1986-05-06 1986-06-11 Connaught Lab Enhancement of antigen immunogenicity
FR2600068B1 (fr) * 1986-06-12 1990-03-23 Pasteur Institut Polypeptides de surfaces cellulaires, isoles et purifies, reconnus par les anticorps responsables de la pathogenie du lupus erythemateux dissemine (led), leur methode d'obtention et leur application au diagnostic ou led
EP0252787A1 (fr) * 1986-06-12 1988-01-13 Institut Pasteur Polypeptides de surfaces cellulaires, isolés et purifiés, reconnus par les anticorps responsables de la pathogénie du lupus érythémateux disséminé (LED), leur méthode d'obtention et leur application au diagnostic du LED
CA1320907C (fr) * 1986-09-23 1993-08-03 Irun Robert Cohen Proteines a membrane cellulaire, compositions contenant de telles proteines et methode de preparation connexe
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
JPS63305247A (ja) * 1987-05-12 1988-12-13 イエダ　リサーチ　アンド　デベロツプメント　カンパニー　リミテツド ワクチン接種の有効性を測定するアツセイ法及びそれに用いるキツト
US6039947A (en) * 1987-06-24 2000-03-21 Autoimmune, Inc. Peptides derived from immunodominant epitopes of myelin basic protein
JPH03502795A (ja) * 1988-02-18 1991-06-27 タン、キム・ゼ 自己免疫疾病に対する抗原
IL85746A (en) * 1988-03-15 1994-05-30 Yeda Res & Dev Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases
US5582831A (en) * 1991-11-26 1996-12-10 Yeda Research And Development Co., Ltd. Anti-tumor vaccines
ES2051989T3 (es) * 1988-10-21 1994-07-01 Akzo Nv Un procedimiento para la manufactura de una inmunotoxina para el tratamiento o profilaxis de una enfermedad autoinmune.
NO306996B1 (no) * 1989-02-17 2000-01-24 Bayer Ag Isolert bukspyttkjerteloey-celle-(ICA)-antigen for in vitro- bruk
IL89431A0 (en) * 1989-02-27 1989-09-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of autoimmune diseases
US6464978B1 (en) 1989-03-21 2002-10-15 The Immune Response Corporation Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
US6077509A (en) * 1990-03-30 2000-06-20 Autoimmune, Inc. Peptide fragments of myelin basic protein
IL99589A0 (en) * 1990-10-03 1992-08-18 Yeda Res & Dev T cell vaccination for prevention and treatment of allergy or graft rejection
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6033661A (en) * 1995-06-07 2000-03-07 Thomas Jefferson University Composition and method for allogenetic mononuclear cell immunotherapy
US5723503A (en) * 1994-09-28 1998-03-03 Thomas Jefferson University Biological treatment for rheumatoid arthritis
US5674487A (en) * 1994-09-28 1997-10-07 Univ Jefferson Method for treating autoimmune diseases
JPH0924269A (ja) * 1995-07-10 1997-01-28 M Technic Kk リン脂質を使ったマイクロカプセルの製造方法
WO1997036614A1 (fr) * 1996-03-29 1997-10-09 Terman David S Proteine staphylococcique polymerisee utilisee dans le traitement de maladies
WO2001080942A1 (fr) 2000-04-25 2001-11-01 Harumi Naganuma Detection non invasive et activation du systeme lymphatique dans le traitement d'une maladie et l'attenuation d'une douleur associee
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
WO2004015070A2 (fr) * 2002-08-08 2004-02-19 Baylor College Of Medicine Isolation et identification de cellules t
PT2016414E (pt) * 2006-05-05 2015-11-24 Opexa Therapeutics Vacina de células t

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
US4046877A (en) * 1975-07-18 1977-09-06 Syntex (U.S.A.) Inc. Method of increasing immunologic competence
JPS53139720A (en) * 1977-05-11 1978-12-06 Green Cross Corp:The Production of antihumanlymphociteglobulin (ahlg)
JPS5524133A (en) * 1978-08-09 1980-02-21 Atsushi Kondo Preparation of anti-human lymphocyte globulin
US4381295A (en) * 1979-04-26 1983-04-26 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells and methods of preparing same
US4390623A (en) * 1980-10-02 1983-06-28 Hooper Trading Company Serum-free and mitogen-free T-cell growth factor and process for making same
US4381292A (en) * 1980-11-14 1983-04-26 The Board Of Trustees Of The Leland Stanford Jr. University Anti-human T-lymphocyte monoclonal antibody
US4406830A (en) * 1981-04-17 1983-09-27 Shanksville Corporation, N.V. Regulatory glycoprotein for immune response and the use thereof in the production of T-cell growth factor
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans

Also Published As

Publication number Publication date
GB2146338A (en) 1985-04-17
JPH0641421B2 (ja) 1994-06-01
CA1235660A (fr) 1988-04-26
DE3433339C2 (de) 1994-02-03
US4634590A (en) 1987-01-06
DE3433339A1 (de) 1985-03-28
IT8422580A0 (it) 1984-09-07
IL69686A0 (en) 1983-12-30
IT1210493B (it) 1989-09-14
ATE83151T1 (de) 1992-12-15
GB2146338B (en) 1988-04-07
IL69686A (en) 1988-03-31
GB8422869D0 (en) 1984-10-17
JPS60155126A (ja) 1985-08-15
FR2553100A1 (fr) 1985-04-12
US4996194A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
FR2553100B1 (fr) Compositions renfermant des proteines de la membrane cellulaire de lymphocytes t, et procede de preparation de cette composition
MX9803264A (es) Metodo y preparaciones para estabilizar materiales biologicos por metodos de secado sin congelamiento.
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
BE880201A (fr) Proteines purifiees, procede de preparation et compositions pharmaceutiques les contenant
EP0158277A3 (fr) Préparations implantables à libération contrôlée de peptides régulateurs et procédé pour leur fabrication
FR2619314B1 (fr) Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
ZA8996B (en) Chemical compounds
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
CA2006658A1 (fr) Une substance anticoagulante tiree de l'urine
IL75086A0 (en) 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,its production and pharmaceutical compositions containing it
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
FR2724320B1 (fr) Nouvel implant pour le traitement des maladies acquises
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
EP0346810A3 (fr) Héparine pour le traitement de lupus
FR2519021B1 (fr) Procede de stabilisation de la serrapeptase, composition contenant cette serrapeptase stabilisee et preparation de cette composition
BE884353A (fr) Nouveaux derives 1-substitues de 3-cycloalcoyl-sulfonyl-pyrrolidine-2, 5-diones, compositions fongicides les contenant et procede pour la preparation des ingredients actifs
IL59842A (en) Biologically active substance 41,200 rp obtained from cells of a micrococcus sedogenes m 78,a process for the preparation thereof and pharmaceutical compositions containing the same
JPS5630993A (en) Manufacture of complement third ingredient from human blood plasma
DK92183D0 (da) 11beta-chlor-delta15-steroider, fremgangsmade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
PT86565A (fr) Procede de preparation de peptides de retroviruses d:immunodeficience humaine (hiv-virus) et de compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse